31 – 40 of 89
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
The Authors' Reply to the Letter “Plasma tumour and metabolism related biomarkers differentiate PAH from HFpEF-PH may improve long-term prognosis”
(
- Contribution to journal › Letter
-
Mark
Data on plasma tumour and metabolism related proteins’ potential in differentiation of HFpEF-PH from PAH and in prognosis of left heart failure patients with pulmonary hypertension
(
- Contribution to journal › Article
-
Mark
Validation of cause of death classification after heart transplantation and cause-specific life expectancy compared to the general population
(
- Contribution to journal › Article
-
Mark
Bioactive adrenomedullin for assessment of venous congestion in heart failure
(
- Contribution to journal › Article
-
Mark
Five year risk assessment and treatment patterns in patients with chronic thromboembolic pulmonary hypertension
(
- Contribution to journal › Article
-
Mark
ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery
(
- Contribution to journal › Article
-
Mark
Bone health and cardiac transplantation
(
- Contribution to journal › Scientific review
-
Mark
Andfåddhet potentiellt allvarligt – kräver strukturerad utredning
(
- Contribution to journal › Article
-
Mark
Elevated plasma WIF-1 levels are associated with worse prognosis in heart failure with pulmonary hypertension
(
- Contribution to journal › Article
-
Mark
Increased biventricular hemodynamic forces in precapillary pulmonary hypertension
(
- Contribution to journal › Article